NBIX - Company ID 0000914475
NEUROCRINE BIOSCIENCES INC (NBIX) reported net income of $478.60M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | $478.60M | +40.2% |
| FY 2024 | $341.30M | +36.7% |
| FY 2023 | $249.70M | +61.6% |
| FY 2022 | $154.50M | +72.4% |
| FY 2021 | $89.60M | -78.0% |
| FY 2020 | $407.30M | +1000.8% |
| FY 2019 | $37.00M | +75.4% |
| FY 2018 | $21.10M | +114.8% |
| FY 2017 |
NEUROCRINE BIOSCIENCES INC (NBIX) reported net income of $478.60M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2011 and fiscal 2025, NEUROCRINE BIOSCIENCES INC's net income grew from $37.57M to $478.60M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| -$142.54M |
| -1.0% |
| FY 2016 | -$141.09M | -58.7% |
| FY 2015 | -$88.93M | -46.9% |
| FY 2014 | -$60.54M | -31.4% |
| FY 2013 | -$46.09M | -1017.2% |
| FY 2012 | $5.03M | -86.6% |
| FY 2011 | $37.57M | - |